NeuroSearch A/S
NeuroSearch A/S announces adjusted annual report

DGAP-News: NeuroSearch A/S /

27.02.2014 / 12:33

---------------------------------------------------------------------

Company announcement
27.02.2014




NeuroSearch A/S (NEUR) announces adjusted annual report 2013, after the Danish
Business Authority has made a decision concerning the control of the company's
annual report for the financial year 2012. 

The adjustment does not affect neither the company's results, equity nor the
net cash flows, while it is merely a question of reclassification of the sale
of the Huntexil(R)project from revenue to gain from divestment of intellectual
property in 2012 and 2013. 

Outlook for 2014
In 2014, NeuroSearch still expects an operating loss at approximately DKK 10
million. The expectations do not take into account any losses or gains which
may result from a potential sale of the remaining assets of the company. 




Allan Andersen
CEO



Contact person
Allan Andersen, CEO, mobile phone +45 4016 3864.

About NeuroSearch
NeuroSearch A/S (NEUR) is listed on NASDAQ OMX Copenhagen A/S.
News Source: NASDAQ OMX


End of Corporate News

---------------------------------------------------------------------

27.02.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English          
Company:     NeuroSearch A/S  
 
 
             Denmark          
ISIN:        DK0010224666     
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
254761 27.02.2014